An eight weeks dose-dense versus a 24 weeks sequential adriamcycin/docetaxel combination as preoperative chemotherapy (CHT) in operable breast cancer (T2-3, N0-2,M0)
In: European Journal of Cancer, Jg. 37 (2001-04-01), S. S145- (2S.)
Online
unknown
Zugriff:
Titel: |
An eight weeks dose-dense versus a 24 weeks sequential adriamcycin/docetaxel combination as preoperative chemotherapy (CHT) in operable breast cancer (T2-3, N0-2,M0)
|
---|---|
Autor/in / Beteiligte Person: | Blohmer, J-U ; Eidtmann, H. ; Merkle, Elisabeth ; Gerber, Bernd ; Schuette, M. ; Kaufmann, Manfred ; Hilfrich, Jörn ; Raab, G. ; G. von Minckwitz ; Caputo, A. |
Link: | |
Zeitschrift: | European Journal of Cancer, Jg. 37 (2001-04-01), S. S145- (2S.) |
Veröffentlichung: | Elsevier BV, 2001 |
Medientyp: | unknown |
ISSN: | 0959-8049 (print) |
DOI: | 10.1016/s0959-8049(01)81028-5 |
Schlagwort: |
|
Sonstiges: |
|